Pharmafile Logo

Increasing patient randomisation rate by 200% for a Top 5 global pharma

Phase IIa Moderate to Severe Hidradenitis Suppurativa Case Study

A Top 5 pharma was looking to randomise 192 patients with moderate to severe HS at 60 sites across the USA, Canada and Australia. Innovative Trials was asked to provide support with patient recruitment and demonstrated that a multi-faceted patient-centric recruitment strategy with a focus on optimising site engagement can overcome potential obstacles and deliver faster, more efficient results.

Read more here

This content was provided by Innovative Trials

Documents for download:

Company Details

 Latest Content from  Innovative Trials 

Free Live Webinar – Uniting Communities for Rare Disease Clinical Trial Success

Join this live webinar focusing on patient recruitment and retention in rare disease trials.

Retention Patch Program

A partnership between Innovative Trials and the non-profit Oliver Patch Project to boost retention in pediatric studies

Innovative Trials recognised at the PMEA Awards 2023 Gala Dinner

Global patient recruitment Innovative Trials took part of the PMEA Awards gala dinner alongside the best players in the pharmaceutical industry.

Innovative Trials launches the Retention Patch Program

Innovative Trials has unveiled a new partnership with the non-profit Oliver Patch Project to boost retention in pediatric studies.

Innovative Trials at the 2023 Lloyds Bank British Business Excellence Awards

Innovative Trials achievements recognized at the Lloyds Bank British Business Excellence Awards

Innovative Trials has been shortlisted in the PMEA Awards

Innovative Trials finalist in the Support Agency of the Year at the annual PMEA industry awards.

A New Era in Patient Recruitment & Retention

Innovative Trials launches ‘first of its kind’ service to boost clinical trial patient recruitment and retention .

Navigator – Revolutionize your patient recruitment and retention

Welcome to the new era in patient recruitment and retention